Asymptomatic SARS-CoV-2 infection in an unvaccinated 97-year-old woman: A case report.
antibodies
asymptomatic infection
coronavirus
elderly
humoral immune response
Journal
Biomedical reports
ISSN: 2049-9442
Titre abrégé: Biomed Rep
Pays: England
ID NLM: 101613227
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
13
09
2021
accepted:
21
10
2021
entrez:
12
11
2021
pubmed:
13
11
2021
medline:
13
11
2021
Statut:
ppublish
Résumé
Coronavirus disease (COVID-19) is an infection caused by the newly detected coronavirus, SARS-CoV-2. The majority of individuals will exhibit mild to moderate illness. Older individuals, and those suffering from co-existing diseases have a greater probability of experiencing a serious illness. Moreover, elderly patients have higher mortality rates than younger patients, especially those who are unvaccinated. Asymptomatic infection is mostly observed in individuals who are younger, as younger patients are more likely to exhibit a stronger immune response to the infection; aging is characterized by the decline immune function. In this article, a rare case of an unvaccinated 97-year-old woman is described who was admitted to Laiko General Hospital due to altered levels of consciousness, hypotension and a hematoma of the thoracic region, and tested positive for SARS-CoV-2 nucleic acid in a nasopharyngeal specimen and positive for IgG antibodies against the SARS-CoV-2 spike protein without a history of consistent manifestations, indicating a past asymptomatic infection.
Identifiants
pubmed: 34765191
doi: 10.3892/br.2021.1483
pii: BR-15-6-01483
pmc: PMC8576401
doi:
Types de publication
Case Reports
Langues
eng
Pagination
107Informations de copyright
Copyright: © Georgakopoulou et al.
Déclaration de conflit d'intérêts
DAS is the Editor-in-Chief for the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating on the final decision, for this article. The other authors declare that they have no competing interests.
Références
Clin Microbiol Infect. 2020 Jun;26(6):767-772
pubmed: 32304745
BMJ. 1990 Nov 10;301(6760):1090-4
pubmed: 2123411
Clin Exp Med. 2021 May;21(2):239-246
pubmed: 33417082
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
J Infect Chemother. 2021 Jan;27(1):70-75
pubmed: 32950393
Int J Biol Sci. 2021 Mar 10;17(4):1119-1124
pubmed: 33867834
J Med Virol. 2021 Oct;93(10):5777-5782
pubmed: 34042191
JCI Insight. 2020 May 21;5(10):
pubmed: 32324595
J Med Virol. 2021 Jan;93(1):250-256
pubmed: 32592501
Sci China Life Sci. 2020 May;63(5):706-711
pubmed: 32146694
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Infect Chemother. 2020 Jun;52(2):154-164
pubmed: 32537961
World J Crit Care Med. 2021 Jul 9;10(4):132-150
pubmed: 34316448
Int J Infect Dis. 2021 Mar;104:458-464
pubmed: 33444755
Front Immunol. 2020 Aug 07;11:1748
pubmed: 32849623
CMAJ. 2004 Nov 23;171(11):1349-52
pubmed: 15557587
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
Crit Care. 2020 Apr 23;24(1):170
pubmed: 32326952
Int J Environ Res Public Health. 2021 Jul 29;18(15):
pubmed: 34360301
Cell Mol Immunol. 2020 Nov;17(11):1180-1182
pubmed: 32963357
J Infect Dis. 2020 May 11;221(11):1770-1774
pubmed: 32179910
J Infect Dev Ctries. 2020 Nov 30;14(11):1252-1255
pubmed: 33296337
Int J Biol Sci. 2020 Mar 15;16(10):1676-1677
pubmed: 32226284
Front Public Health. 2021 Jan 20;8:587374
pubmed: 33553089
In Vivo. 2021 Jan-Feb;35(1):641-648
pubmed: 33402521
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Infect. 2020 Jun;80(6):e14-e18
pubmed: 32171866
Clinics (Sao Paulo). 2020;75:e1912
pubmed: 32428113